LENSAR Total Liabilities 2019-2025 | LNSR
LENSAR total liabilities from 2019 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
|
LENSAR Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $61 |
| 2023 | $36 |
| 2022 | $14 |
| 2021 | $12 |
| 2020 | $12 |
| 2019 | $65 |
| 2018 | $49 |
|
LENSAR Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2025-09-30 | $96 |
| 2025-06-30 | $93 |
| 2025-03-31 | $95 |
| 2024-12-31 | $61 |
| 2024-09-30 | $39 |
| 2024-06-30 | $38 |
| 2024-03-31 | $34 |
| 2023-12-31 | $36 |
| 2023-09-30 | $34 |
| 2023-06-30 | $39 |
| 2023-03-31 | $13 |
| 2022-12-31 | $14 |
| 2022-09-30 | $12 |
| 2022-06-30 | $14 |
| 2022-03-31 | $10 |
| 2021-12-31 | $12 |
| 2021-09-30 | $11 |
| 2021-06-30 | $11 |
| 2021-03-31 | $9 |
| 2020-12-31 | $12 |
| 2020-09-30 | $12 |
| 2020-06-30 | $0 |
| 2020-03-31 | $0 |
| 2019-12-31 | |
| 2019-09-30 | $0 |
| 2018-12-31 | $49 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.134B | $0.053B |
| LENSAR Inc. is a commercial-stage medical device company. It focuses on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. LENSAR Inc. is based in Orlando, Florida. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $215.194B | 25.57 |
| Intuitive Surgical (ISRG) | United States | $206.246B | 80.69 |
| IDEXX Laboratories (IDXX) | United States | $57.022B | 56.63 |
| Edwards Lifesciences (EW) | United States | $50.016B | 33.54 |
| Alcon (ALC) | Switzerland | $39.820B | 26.91 |
| IQVIA Holdings (IQV) | United States | $38.462B | 21.45 |
| Mettler-Toledo (MTD) | United States | $28.903B | 33.82 |
| STERIS (STE) | Ireland | $25.840B | 26.67 |
| DexCom (DXCM) | United States | $25.542B | 35.21 |
| Waters (WAT) | United States | $23.505B | 31.09 |
| Hologic (HOLX) | United States | $16.711B | 17.56 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.990B | 0.00 |
| Globus Medical (GMED) | United States | $12.193B | 25.59 |
| Penumbra (PEN) | United States | $11.775B | 82.83 |
| Masimo (MASI) | United States | $7.610B | 24.39 |
| Glaukos (GKOS) | United States | $6.232B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $5.810B | 18.46 |
| Teleflex (TFX) | United States | $5.325B | 8.49 |
| TransMedics (TMDX) | United States | $4.665B | 55.27 |
| Veracyte (VCYT) | United States | $3.526B | 40.19 |
| LivaNova (LIVN) | United Kingdom | $3.460B | 18.69 |
| Alphatec Holdings (ATEC) | United States | $3.186B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.447B | 11.49 |
| Elekta AB (EKTAY) | Sweden | $2.210B | 20.67 |
| Artivion (AORT) | United States | $2.112B | 96.93 |
| PROCEPT BioRobotics (PRCT) | United States | $2.004B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.740B | 15.19 |
| UFP Technologies (UFPT) | United States | $1.675B | 22.11 |
| AxoGen (AXGN) | United States | $1.537B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.418B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.293B | 0.00 |
| IRadimed (IRMD) | United States | $1.203B | 57.31 |
| Integra LifeSciences Holdings (IART) | United States | $1.031B | 5.59 |
| OPKO Health (OPK) | United States | $1.029B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.899B | 0.00 |
| SiBone (SIBN) | United States | $0.854B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.722B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.630B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.623B | 36.25 |
| AngioDynamics (ANGO) | United States | $0.555B | 0.00 |
| NeuroPace (NPCE) | United States | $0.546B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.523B | 10.43 |
| RxSight (RXST) | United States | $0.519B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.462B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.429B | 11.83 |
| Sight Sciences (SGHT) | United States | $0.426B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.385B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.345B | 57.53 |
| Alpha Tau Medical (DRTS) | Israel | $0.330B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.285B | 2.13 |
| Spectral Diagnostics (EDTXF) | Canada | $0.270B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.238B | 0.00 |
| 908 Devices (MASS) | United States | $0.238B | 0.00 |
| CVRx (CVRX) | United States | $0.237B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.192B | 0.00 |
| Inogen (INGN) | United States | $0.188B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.176B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.175B | 0.00 |
| Solana (HSDT) | United States | $0.159B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.159B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.142B | 0.00 |
| Accuray (ARAY) | United States | $0.112B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.109B | 0.00 |
| Hyperfine (HYPR) | United States | $0.105B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.103B | 0.00 |
| Neuronetics (STIM) | United States | $0.092B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.090B | 0.00 |
| DarioHealth (DRIO) | United States | $0.080B | 0.00 |
| InspireMD (NSPR) | United States | $0.080B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.073B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.064B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.058B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.051B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.024B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.020B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.015B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.18 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |